Healthcare Technology Report July 7, 2025
Wandercraft has raised $75 million in equity and debt to accelerate the launch of Eve, its self-balancing personal exoskeleton slated for 2026, expand clinical adoption of Atalante X, and advance industrial development of its humanoid robot, Calvin-40. The Series D round included participation from Renault Group, the French State-backed PSIM fund via Bpifrance,...







